Literature DB >> 13752346

Progestational agents in the treatment of carcinoma of the endometrium.

R M KELLEY, W H BAKER.   

Abstract

Entities:  

Keywords:  PROGESTERONE/related compounds; UTERUS NEOPLASMS/therapy

Mesh:

Substances:

Year:  1961        PMID: 13752346     DOI: 10.1056/NEJM196102022640503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

1.  THE DIFFICULTIES AND DANGERS OF ORAL CONTRACEPTION.

Authors:  W G MILLS
Journal:  Proc R Soc Med       Date:  1964-03

2.  THE HORMONE-DEPENDENT CANCERS.

Authors:  C B HUGGINS
Journal:  Bull N Y Acad Med       Date:  1963-11

3.  Chemotherapy of malignant disease: a review of theory and practice.

Authors:  G D HART
Journal:  Can Med Assoc J       Date:  1962-03-31       Impact factor: 8.262

Review 4.  Estrongenic steroid hormones in lung cancer.

Authors:  Jill M Siegfried; Laura P Stabile
Journal:  Semin Oncol       Date:  2013-12-12       Impact factor: 4.929

5.  Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.

Authors:  Kari L Ring; Melinda S Yates; Rosemarie Schmandt; Michaela Onstad; Qian Zhang; Joseph Celestino; Suet-Ying Kwan; Karen H Lu
Journal:  Int J Gynecol Cancer       Date:  2017-06       Impact factor: 3.437

Review 6.  Update in cancer chemotherapy: genitourinary tract cancer, Part 6: Cancer of the uterus and vulva.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-06       Impact factor: 1.798

7.  Experimental approaches to endometrial and ovarian cancer.

Authors:  M G Brush
Journal:  Postgrad Med J       Date:  1973-02       Impact factor: 2.401

8.  Effects of cortisone acetate, methylprednisolone and medroxyprogesterone on wound contracture and epithelization in rabbits.

Authors:  W Lenco; M Mcknight; A S Macdonald
Journal:  Ann Surg       Date:  1975-01       Impact factor: 12.969

9.  Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?

Authors:  Flora Zagouri; George Bozas; Eftichia Kafantari; Marinos Tsiatas; Nikitas Nikitas; Meletios-A Dimopoulos; Christos A Papadimitriou
Journal:  Obstet Gynecol Int       Date:  2010-02-02

Review 10.  Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.

Authors:  L G Crowley; S A Duwe
Journal:  Calif Med       Date:  1969-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.